Advanced Enzyme Technologies Ltd. (ADVENZYMES)
BSE
280.20
-4.00 (-1.41%)
Closed
Nov 6, 2026
Day's Range
278.90287.00
52 wk Range
247.10419.80
Financial Statements - ADVENZYMES - Advanced Enzyme Technologies Ltd.
Revenue
7.44B▲ 17.0%
Net Income
1.73B▲ 29.6%Net Margin 23.3%
EBITDA
2.58B▲ 16.0%
Free Cash Flow
1.04B▼ 3.1%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 7.44B | 6.36B | 6.23B | 5.40B | 5.28B | 5B |
| Cost of Goods | 2.06B | 1.64B | 1.59B | 1.42B | 1.19B | 1.05B |
| Gross Profit | 5.37B | 4.71B | 4.64B | 3.97B | 4.09B | 3.94B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.92B | 1.60B | 1.72B | 1.38B | 1.68B | 2.09B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 2.32B | 1.87B | 1.87B | 1.40B | 1.71B | 2.10B |
| Income Tax | 589.28M | 533.90M | 508.70M | 365.22M | 472.59M | 588.45M |
| Net Income | 1.73B | 1.33B | 1.36B | 1.03B | 1.23B | 1.51B |
| EPS Basic | 15.08 | 11.72 | 11.92 | 9.45 | 10.7 | 13.06 |
| EPS Diluted | 15.06 | 11.71 | 11.92 | 9.45 | 10.68 | 13.04 |
| Basic Shares Outstanding | 111.90M | 111.85M | 111.82M | 111.81M | 111.77M | 111.69M |
| Diluted Shares Outstanding | 111.90M | 111.85M | 111.82M | 111.81M | 111.77M | 111.69M |
| Ebit | 2.35B | 1.90B | 1.90B | 1.42B | 1.72B | 2.11B |
| Ebitda | 2.58B | 2.22B | 2.34B | 1.86B | 2.07B | 2.40B |
| Net Income Continuous Operations | 2.32B | 1.87B | 1.87B | 1.40B | 1.71B | 2.10B |
| Minority Interests | -48.89M | -28.59M | -36.46M | 17.73M | -42.17M | -53.56M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
